Vaccine manufacturing in Africa is still nascent, especially in the upstream segments of the value chain, such as antigen production and other drug-substance manufacturing processes.
![Final GIF file uploaded in April folder](/~/media/mckinsey/featured%20insights/charting%20the%20path%20to%20the%20next%20normal/2021/may/gif%20charts/africavaccine-gif-v1-ex2.gif)
To read the article, see “Africa needs vaccines. What would it take to make them here?,” April 14, 2021.